Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Medicare policy slows Epogen sales

Aug. 6, 1997

Knoll reaches settlement on Synthroid class action lawsuit

Aug. 6, 1997

GnRH antagonists in the pipeline at Merck & Co.

Aug. 6, 1997

New direction in NOS research: Potential application in gene therapy of impotence

Aug. 5, 1997

Lilly creates new business unit dedicated to women's health

Aug. 5, 1997

Tonalin CLA reduces body fat

Aug. 5, 1997

Rezulin receives FDA marketing clearance for type 2 diabetes

Aug. 5, 1997

Sibutramine: New hope for obese patients

Aug. 5, 1997

Bioniche to manufacture Orphan Medical's Intrachol

Aug. 5, 1997

U.S. patent issues for bone substitute technology

Aug. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...